ArticleRadiology case reports2026
Novel application of transcervical radiofrequency ablation for symptomatic cystic adenomyosis. Case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cystic adenomyosis is a rare subtype of adenomyosis characterized by cystic lesions within the myometrium, causing significant dysmenorrhea and pelvic pain. Traditional surgical treatments, such as laparoscopic or hysteroscopic excision, can be challenging, particularly with deep intramyometrial lesions, and risk uterine tissue trauma potentially impairing future fertility. We report the first known case of symptomatic cystic adenomyosis successfully treated using transcervical intrauterine ultrasound-guided radiofrequency ablation (RFA). A 35-year-old woman with severe dysmenorrhea, hypermenorrhea, and a 2.5 cm cystic adenomyotic lesion located deeply within the anterior myometrium underwent combined transcervical RFA (Sonata System) and laparoscopic excision of superficial peritoneal endometriosis. Real-time intraoperative ultrasound enabled safe and precise ablation with minimal myometrial injury. Six-month postoperative follow-up demonstrated complete resolution of the cystic adenomyosis and significant symptomatic relief, with only minimal residual scar tissue. Compared to conventional surgical methods, transcervical RFA offered substantial advantages including minimal invasiveness, preservation of uterine architecture, rapid recovery, and fertility preservation. This case highlights transcervical RFA as a promising, uterus-sparing therapeutic approach for managing complex cystic adenomyosis lesions, especially beneficial for women desiring future pregnancy. Further studies are warranted to evaluate long-term outcomes and broader applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.